Compare CABR & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CABR | IRIX |
|---|---|---|
| Founded | 2020 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.2M | 20.2M |
| IPO Year | N/A | 1996 |
| Metric | CABR | IRIX |
|---|---|---|
| Price | $1.34 | $0.94 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 710.2K | 98.9K |
| Earning Date | 01-01-0001 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $4,493.00 | ★ $50,647,000.00 |
| Revenue This Year | N/A | $9.61 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4.58 |
| 52 Week Low | $0.06 | $0.78 |
| 52 Week High | $6.00 | $1.89 |
| Indicator | CABR | IRIX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 45.74 |
| Support Level | N/A | $0.91 |
| Resistance Level | N/A | $0.96 |
| Average True Range (ATR) | 0.00 | 0.04 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 46.52 |
Caring Brands Inc is a consumer wellness company specializing in over-the-counter (OTC) and cosmetic products.support health and wellness through the research and development of over-the-counter (OTC) products and intellectual property. It product pipeline addresses a range of conditions, including hair loss, eczema, burns, and sexual wellness. Company's majority of revenue is generated through the sales of OTC and consumer products and licensing royalties.
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.